Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Physical Performance and Quality of Life in Children With Brain Tumors

Key facts

Where
Cairo, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 7 and 10 years old?

Source: NCT07810673, who can take part

Where in Egypt

  • Maadi Military HospitalCairo, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Sarah Mohammed El-Abasiri
Trial code
NCT07810673
Record updated
9 September 2026
Original description
This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children. The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional impact of the condition.Read full original descriptionShow less

ASSESSMENT OF PHYSICAL PERFORMANCE AND QUALITY OF LIFE IN CHILDREN WITH BRAIN TUMORS.

This study is designed to assess physical performance and quality of life in children with posterior fossa brain tumors compared to healthy children. The trial evaluates parameters such as physical endurance, balance, muscle strength, gait characteristics, and quality of life measures to understand the functional impact of the condition.

Inclusion: - Children aged 7 to 10 years; Confirmed diagnosis of posterior fossa brain tumors; Medically stable and able to perform physical evaluations; Age-matched healthy children aged 7 to 10 years; No history of neurological, musculoskeletal, or oncological disorders.

Exclusion: Other concurrent major medical or orthopedic conditions affecting physical performance; Associated severe cognitive or visual impairments preventing test comprehension.

ClinicalTrials.gov NCT07810673